AR240175A1 - Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma. - Google Patents

Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.

Info

Publication number
AR240175A1
AR240175A1 AR312348A AR31234888A AR240175A1 AR 240175 A1 AR240175 A1 AR 240175A1 AR 312348 A AR312348 A AR 312348A AR 31234888 A AR31234888 A AR 31234888A AR 240175 A1 AR240175 A1 AR 240175A1
Authority
AR
Argentina
Prior art keywords
cell line
monoclonal antibody
hybridoma technique
antibody derived
line produced
Prior art date
Application number
AR312348A
Other languages
English (en)
Spanish (es)
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of AR240175A1 publication Critical patent/AR240175A1/es

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00Apparatus for electrographic processes using a charge pattern
    • G03G15/65Apparatus which relate to the handling of copy material
    • G03G15/6517Apparatus for continuous web copy material of plain paper, e.g. supply rolls; Roll holders therefor
    • G03G15/6526Computer form folded [CFF] continuous web, e.g. having sprocket holes or perforations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G15/00Apparatus for electrographic processes using a charge pattern
    • G03G15/14Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base
    • G03G15/16Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer
    • G03G15/1695Apparatus for electrographic processes using a charge pattern for transferring a pattern to a second base of a toner pattern, e.g. a powder pattern, e.g. magnetic transfer with means for preconditioning the paper base before the transfer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00Apparatus for electrophotographic processes
    • G03G2215/00362Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00367The feeding path segment where particular handling of the copy medium occurs, segments being adjacent and non-overlapping. Each segment is identified by the most downstream point in the segment, so that for instance the segment labelled "Fixing device" is referring to the path between the "Transfer device" and the "Fixing device"
    • G03G2215/00409Transfer device
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00Apparatus for electrophotographic processes
    • G03G2215/00362Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443Copy medium
    • G03G2215/00451Paper
    • G03G2215/00455Continuous web, i.e. roll
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00Apparatus for electrophotographic processes
    • G03G2215/00362Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00443Copy medium
    • G03G2215/00451Paper
    • G03G2215/00455Continuous web, i.e. roll
    • G03G2215/00459Fan fold, e.g. CFF, normally perforated
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03GELECTROGRAPHY; ELECTROPHOTOGRAPHY; MAGNETOGRAPHY
    • G03G2215/00Apparatus for electrophotographic processes
    • G03G2215/00362Apparatus for electrophotographic processes relating to the copy medium handling
    • G03G2215/00535Stable handling of copy medium
    • G03G2215/00607Debris handling means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR312348A 1987-11-02 1988-10-14 Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma. AR240175A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/116,514 US5002869A (en) 1987-11-02 1987-11-02 Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes

Publications (1)

Publication Number Publication Date
AR240175A1 true AR240175A1 (es) 1990-02-28

Family

ID=22367627

Family Applications (1)

Application Number Title Priority Date Filing Date
AR312348A AR240175A1 (es) 1987-11-02 1988-10-14 Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.

Country Status (13)

Country Link
US (1) US5002869A (fr)
EP (1) EP0387286B1 (fr)
JP (1) JP3158119B2 (fr)
CN (1) CN1033074A (fr)
AR (1) AR240175A1 (fr)
AU (1) AU618563B2 (fr)
CA (1) CA1305928C (fr)
DE (1) DE3855201T2 (fr)
ES (1) ES2017806A6 (fr)
IE (1) IE62056B1 (fr)
IL (1) IL88160A0 (fr)
WO (1) WO1989004175A1 (fr)
ZA (1) ZA887771B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3048632B2 (ja) * 1989-06-02 2000-06-05 ザ ジョーンズ ホプキンズ ユニヴァーシティ スクール オブ メディスン 白血球付着レセプターβ鎖に対するモノクローナル抗体と、この抗体の製造方法と、その応用
US5100378A (en) * 1989-06-09 1992-03-31 Neorx Corporation Enhancement of target cell localization of lymphoid cells
NZ236792A (en) * 1990-01-19 1993-05-26 Merck & Co Inc Recombinant human anti-cd18 antibody, murine 1b4 heavy or light chain variable region, dna, vectors, mammalian host and pharmaceutical compositions
US5273738A (en) * 1990-03-03 1993-12-28 Fred Hutchinson Cancer Research Center Radiation delivery to lymphoid and marrow tissues
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
US5223241A (en) * 1990-10-01 1993-06-29 The General Hospital Corporation Method for early detection of allograft rejection
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
MX9305070A (es) * 1992-08-21 1994-04-29 Genentech Inc Compocicion farmaceutica que contiene un antagonista de lfa-1 para el tratamiento de transtornos o desordenes mediados por el lfa-1
FR2700471B1 (fr) * 1993-01-21 1995-04-07 Pasteur Merieux Serums Vacc Utilisation d'anticorps monoclonaux anti-LFA-1 pour la préparation d'un médicament destiné à prévenir le rejet des greffes d'organes solides et médicaments obtenus.
US5651970A (en) * 1993-03-19 1997-07-29 Allen; Allen D. Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
EP0690725B1 (fr) * 1993-03-19 2004-05-19 ALLEN, D. Allen Procedes pour inhiber la maladie associee au vih au moyen d'anticorps monoclonaux diriges contre les lymphocytes t cytotoxiques anti-self
US6534057B2 (en) 1993-03-19 2003-03-18 Allen D. Allen Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
AU6256796A (en) * 1995-06-06 1996-12-24 D. Allen Allen Method for treating molluscum contagiosum resulting from hiv infection
US6001356A (en) * 1995-09-29 1999-12-14 Rush-Presbyterian-St. Luke's Medical Center Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
DE60042735D1 (de) 1999-03-19 2009-09-24 Genentech Inc Behandlung von lfa-1 assozieerten krankheiten durch gesteigerte dosen von lfa-1 antagonist
US6582698B1 (en) * 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
US6919077B2 (en) * 2002-09-27 2005-07-19 Aids Research, Llc LFA-1 alpha subunit antibodies and methods of use
WO2005113003A2 (fr) * 2004-04-16 2005-12-01 Genentech, Inc. Methode permettant d'augmenter l'appauvrissement des lymphocytes b
CA2568570A1 (fr) * 2004-06-09 2005-12-29 Genentech, Inc. Procede de traitement du granulome annulaire ou sarcoide
US7789282B2 (en) * 2007-08-14 2010-09-07 Chervon Limited Nailer device
WO2013040188A1 (fr) * 2011-09-15 2013-03-21 Cytodyn, Inc. Anticorps anti-cd11a et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4677056A (en) * 1983-08-18 1987-06-30 Sloan-Kettering Institute For Cancer Research Monoclonal antibody subsetting human helper and killer T-cells and method
GB8605316D0 (en) * 1986-03-04 1986-04-09 Royal Free Hosp School Med Immunosuppression
EP0299073B1 (fr) * 1987-01-24 1995-11-29 Dai Nippon Insatsu Kabushiki Kaisha Support d'enregistrement optique et production de ce support

Also Published As

Publication number Publication date
ZA887771B (en) 1990-06-27
US5002869A (en) 1991-03-26
DE3855201D1 (de) 1996-05-15
IE62056B1 (en) 1994-12-14
ES2017806A6 (es) 1991-03-01
WO1989004175A1 (fr) 1989-05-18
EP0387286A1 (fr) 1990-09-19
IL88160A0 (en) 1989-06-30
AU618563B2 (en) 1992-01-02
JP3158119B2 (ja) 2001-04-23
JPH03501804A (ja) 1991-04-25
EP0387286B1 (fr) 1996-04-10
CA1305928C (fr) 1992-08-04
CN1033074A (zh) 1989-05-24
EP0387286A4 (en) 1990-10-10
AU2611488A (en) 1989-06-01
IE883062L (en) 1989-05-02
DE3855201T2 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
AR240175A1 (es) Una linea celular producida por tecnica de hibridoma y un anticuerpo monoclonal derivado de la misma.
DE68914244T2 (de) Monoklonaler Antikörper.
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
DE3879452T2 (de) Chimaere antikoerper.
NO822853L (no) Antigenbestemmelse.
DE3885355T2 (de) Monoklonale Antikörper.
DK191989D0 (da) Tumor-associeret glycoproteinantigen, antistoffer mod antigenet samt hybridoma-cellelinie, der producerer antistofferne
NO873774D0 (no) Monoklonale eller polyklonale antistoffer.
NO862920L (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
DK557289D0 (da) Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen
DE3780256T2 (de) Anti-pci-monoklonaler antikoerper.
DE3888437T2 (de) Immobilisierte Antikörper.
DE3587714T2 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
FI885956A (fi) Monoklonaliska antikroppar mot lungkarcinom.
NO873488L (no) Monoklonale antistoffer.
DE3785795D1 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
NO890116D0 (no) Monoklonale antistoffer.
DE69023717T2 (de) Monoklonaler Antikörper.
FI893928A (fi) Monoklonala motkroppar.
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
IT8821702A0 (it) Nuovo anticorpo monoclonale.
MX12068A (es) Linea celular producida mediante una tecnica de hibridoma y anticuerpo monocional obtenido.
DE3750534D1 (de) Mit dem TRF (Interleukin-5) reagierender monoklonaler Antikörper.
DE68916088T2 (de) Anti-CPBII-monoklonaler Antikörper.